...
首页> 外文期刊>Parasites Vectors >Assessment of methods used to determine the safety of the topical insect repellent N,N-diethyl-m-toluamide (DEET)
【24h】

Assessment of methods used to determine the safety of the topical insect repellent N,N-diethyl-m-toluamide (DEET)

机译:评估用于确定局部驱虫剂N,N-二乙基-间甲苯胺(DEET)的安全性的方法

获取原文

摘要

N,N-diethyl-m-toluamide (DEET) has been registered for commercial use as an insect repellent for over five decades, and is used widely across the world. Concerns over the safety of DEET first emerged during the 1980s after reports of encephalopathy following DEET exposure, particularly in children. However, the role of DEET in either the illness or deaths was and remains purely speculative. In response to these cases a number of reviews and investigations of DEET safety were carried out. Here we examine the methods used and information available to determine the safety of DEET in humans. Animal testing, observational studies and intervention trials have found no evidence of severe adverse events associated with recommended DEET use. Minor adverse effects noted in animal trials were associated with very large doses and were not replicated between different test species. The safety surveillance from extensive humans use reveals no association with severe adverse events. This review compares the toxicity assessment using three different models to define the risk assessment and safety threshold for DEET use in humans and discusses the clinical consequences of the thresholds derived from the models. The theoretical risks associated with wearing an insect repellent should be weighed against the reduction or prevention of the risk of fatal or debilitating diseases including malaria, dengue, yellow fever and filariasis. With over 48 million European residents travelling to regions where vector borne diseases are a threat in 2009, restricting the concentration of DEET containing repellents to 15% or less, as modelled in the 2010 EU directive, is likely to result in extensive sub-therapeutic activity where repellents are infrequently applied. Future European travellers, as a consequence of inadequate personal protection, could potentially be at increased risk of vector borne diseases. Risk assessments of repellents should take these factors into account when setting safe limits.
机译:N,N-二乙基间甲苯胺(DEET)已被注册为驱虫剂商业使用已有五十年之久,并在世界范围内得到广泛使用。有关DEET安全性的担忧最初是在1980年代,在有DEET暴露后发生脑病的报道之后,尤其是在儿童中。但是,DEET在疾病或死亡中的作用过去是,而且仍然纯粹是推测性的。针对这些情况,对DEET安全性进行了许多审查和调查。在这里,我们检查了用于确定DEET对人体安全性的方法和可用信息。动物试验,观察性研究和干预试验均未发现与推荐使用DEET相关的严重不良事件的证据。动物试验中指出的轻微不良反应与非常大的剂量有关,并且在不同的测试物种之间没有重复。人类广泛使用的安全监控表明,与严重不良事件无关。这篇综述使用三种不同的模型对毒性评估进行了比较,以定义在人体中使用DEET的风险评估和安全性阈值,并讨论了从模型得出的阈值的临床后果。应权衡与使用驱虫剂相关的理论风险,以减少或预防致命或使人衰弱的疾病(包括疟疾,登革热,黄热病和丝虫病)的风险。 2009年有超过4800万欧洲居民前往媒介传播疾病威胁地区,按照2010年欧盟指令的模型,将含有驱蚊剂的DEET的浓度限制在15%或以下,可能会导致广泛的亚治疗活动很少使用驱虫剂的地方。由于个人保护不足,未来的欧洲旅行者可能会增加病媒传播疾病的风险。设置安全限值时,对驱虫剂的风险评估应考虑这些因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号